Please wait while the formulary information is being retrieved.
LIQ-10 (ubidecarenone)
100 mg/5 mL oral syrup
- Dosage information is not available
50 mg-15 unit/5 mL oral syrup
- Dosage information is not available
- None
Contraindicated
- None
Severe
Moderate
- None
- None
Contraindicated
- None
Severe
Moderate
- Biliary obstruction
- Disease of liver
- Hypotension
LIQ-10 (ubidecarenone)
- None
- None
More Frequent
Severe
Less Severe
- None
- None
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- None
Less Severe
- Abnormal hepatic function tests
- Anorexia
- Diarrhea
- Gastrointestinal irritation
- Nausea
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
None
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Ubidecarenone (coenzyme Q10)
Insufficient human data available
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient human data available |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
Formulary Reference Tool